Cresset Asset Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
105,939
+5,902
+6% +$139K 0.01% 582
2026
Q1
$1.5M Sell
100,037
-130,091
-57% -$2.22M 0.01% 642
2025
Q4
$3.35M Sell
230,128
-24,149
-9% -$421K 0.01% 448
2025
Q3
$4.56M Sell
254,277
-356,980
-58% -$5.24M 0.02% 367
2025
Q2
$10.4M Buy
611,257
+460,879
+306% +$4.61M 0.05% 210
2025
Q1
$1.09M Buy
150,378
+114,710
+322% +$1.31M 0.01% 744
2024
Q4
$501K Buy
35,668
+5,022
+16% +$74.2K ﹤0.01% 1082
2024
Q3
$363K Hold
30,646
﹤0.01% 1709
2024
Q2
$285K Sell
30,646
-14,732
-32% -$75.3K ﹤0.01% 1743
2024
Q1
$161K Buy
+45,378
New +$157K ﹤0.01% 1797

Other funds holding CORZ

Cresset Asset Management's CORZ Position: Q2 2026 in Review

Cresset Asset Management increased its Core Scientific (CORZ) stake by 5.9% in Q2 2026, buying an estimated $139K and bringing the position to 105,939 shares worth $2.71M. The position accounts for 0.01% of the portfolio, ranked #582.

Cresset Asset Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.4M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Cresset Asset Management held 105,939 shares of Core Scientific worth $2.71M as of Q2 2026.
  • Cresset Asset Management bought 5,902 Core Scientific shares in Q2 2026, an estimated $139K.
  • Core Scientific made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #582 holding.
  • Cresset Asset Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Cresset Asset Management's Core Scientific position peaked at $10.4M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.